These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16394792)

  • 1. Hepatitis C treatment in drug users: perception versus evidence.
    Sylvestre D
    Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):129-30. PubMed ID: 16394792
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating intravenous drug users with hepatitis C infection: an opportunity in some settings.
    Chong VH; Jamaludin AZ; Jacob AP; Jalihal A
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1121. PubMed ID: 16957520
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic hepatitis C in active drug users.
    Davis GL; Rodrigue JR
    N Engl J Med; 2001 Jul; 345(3):215-7. PubMed ID: 11463020
    [No Abstract]   [Full Text] [Related]  

  • 4. [Is hepatitis C important for drug addicts?].
    Aavitsland P
    Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1623. PubMed ID: 19721475
    [No Abstract]   [Full Text] [Related]  

  • 5. Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes.
    Robaeys G; Van Vlierberghe H; Matheï C; Van Ranst M; Bruckers L; Buntinx F; ;
    Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):159-66. PubMed ID: 16394797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Virus Treatment and Injection Drug Users: It Is Time to Separate Fact From Fiction.
    McCance-Katz EF; Valdiserri RO
    Ann Intern Med; 2015 Aug; 163(3):224-5. PubMed ID: 26120801
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
    Zanini B; Lanzini A
    Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
    Remy AJ; Wenger H; Bouchkira H
    Presse Med; 2014 Dec; 43(12 Pt 1):1314-6. PubMed ID: 25307441
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C Virus Treatment and Persons Who Inject Drugs.
    McCance-Katz EF; Valdiserri RO
    Ann Intern Med; 2016 Feb; 164(3):203-4. PubMed ID: 26829915
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C Virus Treatment and Persons Who Inject Drugs.
    Grebely J; Dore GJ; Greenwald R; Swan T; Barua S; Taylor LE
    Ann Intern Med; 2016 Feb; 164(3):203. PubMed ID: 26829914
    [No Abstract]   [Full Text] [Related]  

  • 11. Is the end of chronic hepatitis C virus infection in sight?
    McCaughan GW
    Med J Aust; 2012 Jun; 196(10):614. PubMed ID: 22676864
    [No Abstract]   [Full Text] [Related]  

  • 12. [Short-time hepatitis C treatment and drug abuse].
    Kristensen Ø; Rysstad O; Gallefoss F
    Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2498; author reply 2499. PubMed ID: 19997144
    [No Abstract]   [Full Text] [Related]  

  • 13. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
    Gazdag G; Horvath G; Szabo O; Ungvari GS
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients.
    Bruggmann P; Falcato L; Dober S; Helbling B; Keiser O; Negro F; Meili D;
    J Viral Hepat; 2008 Oct; 15(10):747-52. PubMed ID: 18637072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hepatitis C in intravenous drug users].
    Filoche B
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B252-6. PubMed ID: 12180298
    [No Abstract]   [Full Text] [Related]  

  • 16. Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.
    Manolakopoulos S; Deutsch MJ; Anagnostou O; Karatapanis S; Tiniakou E; Papatheodoridis GV; Georgiou E; Manesis E; Tzourmakliotis D; Archimandritis AJ
    Liver Int; 2010 Nov; 30(10):1454-60. PubMed ID: 20846344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of chronic hepatitis C treatment outcome between intravenous drug users and non-intravenous drug users.
    Bojovic K; Simonovic J; Katanic N; Milosevic I; Pesic I; Delic D; Svirtlih N; Jevtovic DJ
    Biomed Pharmacother; 2013 Jul; 67(6):517-20. PubMed ID: 23639229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment.
    Lewis H; Kunkel J; Axten D; Dalton J; Gardner H; Tippett A; Wynne S; Wilkinson M; Foster GR
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1258-63. PubMed ID: 27487966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scale-up of hepatitis C treatment in prisons is key to national elimination.
    Papaluca T; Hellard ME; Thompson AJV; Lloyd AR
    Med J Aust; 2019 May; 210(9):391-393.e1. PubMed ID: 30968417
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis of depression in former injection drug users with chronic hepatitis C.
    Scott JD; Wang CC; Coppel E; Lau A; Veitengruber J; Roy-Byrne P
    J Clin Gastroenterol; 2011; 45(5):462-7. PubMed ID: 21293293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.